title: Infectious bronchitis immunity: its study in chickens experimentally infected with mixtures of infectious bronchitis virus and Escherichia coli.
abstract: The live infectious bronchitis (IB) vaccine, H120, protected chickens against intranasal challenge with a mixture of Escherichia coli strains (E. coli Pool) and IB virus (IBV) strains of the same (Massachusetts) serotype as H120; it usually also protected against challenge with the E. coli Pool and IBV strains of other serological types. When these challenge strains were themselves used as vaccines they usually protected against challenge with a mixture of the E. coli Pool and an IBV strain of the Massachusetts serotype (VF69-149) or an IBV strain not of the Massachusetts serotype (HVI-116). Poor protection, when observed, was most common in those experiments involving a minority of the IBV strains that had been incriminated in recent outbreaks of disease in vaccinated flocks of chickens. Much lower concentrations of IBV strain VF69-149 and E. coli O18 were found in the nose, trachea and spleen of H120-vaccinated chickens killed at different times after they were given a mixture of these organisms than were found in these sites in similarly challenged unvaccinated chickens. Some protection against challenge with IBV and the E. coli Pool was also observed in chickens vaccinated with an inactivated IBV strain; it was much less effective than that obtained following vaccination with the corresponding live IBV strain.
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D000917:Antibody Formation; D002645:Chickens; D003332:Coronaviridae / Q000276:immunology*; D003333:Coronaviridae Infections / Q000150:complications / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D004195:Disease Models, Animal; D004927:Escherichia coli Infections / Q000150:complications / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D001351:Infectious bronchitis virus / Q000276:immunology*; D011201:Poultry Diseases / Q000150:complications / Q000276:immunology / Q000517:prevention & control*; D013997:Time Factors; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology*
chemical_list: D014765:Viral Vaccines